Fri, 16 Jan 2026
The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly in the obesity drug space.
>>
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025